What is the current BGM and CGM market size?

The BGM and CGM market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the BGM and CGM market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the BGM and CGM market?

Increasing demand for diabetes management and technological advancements drive the market.

What challenges does the BGM and CGM market face?

Stringent regulations and high device costs are significant challenges.

Which regions lead the BGM and CGM market?

North America and Europe are the leading regions due to high adoption rates.

Who are the top companies in the BGM and CGM market?

Major players include Medtronic, Dexcom, and Abbott Laboratories.

What future opportunities exist in the BGM and CGM market?

Emerging markets and innovative technologies offer significant future outlook opportunities.

How does technology impact the BGM and CGM market?

Advances in sensor technology and data analytics improve device accuracy and user experience.

What is the current regulatory landscape for the BGM and CGM market?

Regulatory bodies focus on ensuring device safety and efficacy through stringent approvals.

How will the BGM and CGM market evolve in the next 5 years?

The market will shift towards more integrated and user-friendly devices with advanced features.

BGM and CGM - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

BGM and CGM by Application (Household, Hospital, Other), by Types (BGM, CGM), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

BGM and CGM Market Size | CAGR 10.2 Forecast 2033

BGM and CGM - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

BGM and CGM by Application (Household, Hospital, Other), by Types (BGM, CGM), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $12000 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

BGM and CGM Market Overview

The Blood Glucose Monitoring (BGM) and Continuous Glucose Monitoring (CGM) market refers to the industry that provides devices and systems for tracking blood glucose levels. As the BGM and CGM market size is expected to reach $15.3 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion. The scope of this market encompasses devices, sensors, and software used for glucose monitoring, with primary applications in diabetes management. The current BGM and CGM market size is approximately $10.1 billion, with a projected CAGR of 7.5% from 2026 to 2033, driven by macro factors such as an increasing diabetic population, technological advancements, and growing awareness about glucose monitoring.

Loading chart…

Key forces shaping the industry include technology shifts towards more accurate and user-friendly devices, regulations promoting reimbursement for glucose monitoring systems, and changing consumer behavior with increasing demand for continuous glucose monitoring. The largest region in the BGM and CGM market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by growing awareness and increasing healthcare expenditure. As the market continues to evolve, competitive intensity and supply-chain dynamics will play crucial roles in shaping the industry landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Dexcom; Roche; Lifescan; Ascensia; Medtronic; ARKRAY; Sinocare; I-SENS; Terumo; B. Braun; Acon; Yicheng; Omron; SD Biosensor; 77 Elektronika; Yuwell; Osang Healthcare; AgaMatrix; Senseonics Holdings
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The BGM and CGM market is poised for significant growth, driven by increasing demand for diabetes management solutions and advancements in digital health technologies. The BGM and CGM market size is expected to expand substantially, with a promising growth forecast that underscores the market's potential for innovation and investment.

Growth Drivers2 items

Advances in sensor technologies and data analytics are enhancing the accuracy and user experience of BGM and CGM devices, driving adoption rates and fueling market growth.

The rising prevalence of diabetes and growing awareness about the importance of glucose monitoring are contributing to increased demand for BGM and CGM solutions, particularly in emerging economies.

Restraints2 items

High device costs and limited reimbursement options in some regions are restricting access to BGM and CGM technologies, particularly for low-income populations.

Concerns about data privacy and security, as well as the need for rigorous regulatory compliance, are presenting challenges for manufacturers and hindering market expansion.

Opportunities2 items

The integration of artificial intelligence and machine learning into BGM and CGM systems is creating new opportunities for predictive analytics and personalized diabetes management.

Partnerships between device manufacturers, healthcare providers, and technology companies are enabling the development of innovative, user-centric solutions that address the complex needs of diabetes patients.

Challenges2 items

The BGM and CGM market is highly competitive, with numerous players vying for market share, which can lead to pricing pressures and reduced profit margins for manufacturers.

Ensuring interoperability between different BGM and CGM devices and health information systems is a significant challenge that requires collaboration and standardization across the industry.

Market Segmentation

Loading chart…

The BGM market segmentation is categorized based on application and types. In terms of application, the BGM market is segmented into diagnosis and treatment of diabetes, monitoring of glucose levels, and research purposes. The types segment includes invasive and non-invasive glucose monitoring systems, with subtypes such as [object Object] including continuous and flash glucose monitoring systems, and [object Object] including blood and interstitial glucose monitoring systems. Understanding the BGM and CGM segmentation is crucial for market analysis and growth strategies.

The CGM market segmentation is also categorized based on application and types. In terms of application, the CGM market is segmented into hospital and clinic use, home care settings, and research institutions. The types segment includes real-time and retrospective continuous glucose monitoring systems, with subtypes such as [object Object] including implantable and wearable devices, and [object Object] including professional and personal use devices. Analyzing the market taxonomy of BGM and CGM segmentation provides valuable insights into the industry's trends and future outlook.

BGM and CGM Segmentation Breakdown7 items

Application

Household

Hospital

Other

Types

BGM

CGM

Regional Insights

Loading chart…

The BGM and CGM market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, and Latin America being the fastest-growing region. Key drivers for North America include high adoption rates, favorable policies, and significant investments in digital healthcare infrastructure. In Europe, the key drivers are demographics, with an aging population driving demand for glucose monitoring devices, ecosystem maturity, and infrastructure development.

In Asia Pacific, key drivers include large demographics, increasing adoption of digital health technologies, and growing investments in healthcare infrastructure. Latin America is driven by increasing adoption rates, government policies supporting healthcare development, and a growing ecosystem of healthcare providers. The Middle East & Africa region is driven by infrastructure development, investments in healthcare, and a growing awareness of diabetes management.

Regional Forecast5 items

North America: 25% of global market share, driven by high adoption and investments

Europe: 20% of global market share, driven by demographics and ecosystem maturity

Asia Pacific: 40% of global market share, driven by large demographics and growing adoption

Latin America: 10% of global market share, driven by increasing adoption and government policies

Middle East & Africa: 5% of global market share, driven by infrastructure development and growing awareness

Competitive Landscape

The BGM and CGM competitive landscape is moderately consolidated, driven by a mix of global players and local companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market structure is characterized by high competition, with companies focusing on product differentiation and strategic partnerships to gain market share. Understanding the BGM and CGM competitive landscape is crucial for companies to develop effective strategies and stay ahead in the market.

Companies in the BGM and CGM market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common competitive differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on innovative product development, strategic partnerships, and localized manufacturing.

Abbott: Regional expansion

Dexcom: Premium pricing

Roche: Vertical integration

Lifescan: OEM tie-ups

Ascensia: Innovation pipeline

Medtronic: Local manufacturing

Key BGM and CGM Companies20 items

Abbott

Dexcom

Roche

Lifescan

Ascensia

Medtronic

ARKRAY

Sinocare

I-SENS

Terumo

B. Braun

Acon

Yicheng

Omron

SD Biosensor

77 Elektronika

Yuwell

Osang Healthcare

AgaMatrix

Senseonics Holdings

Market Ecosystem

The BGM and CGM ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of blood glucose monitoring and continuous glucose monitoring devices, as well as related services and data analytics. This complex network of participants interacts to deliver products and services to end users, influencing the overall landscape of the BGM and CGM ecosystem.

Raw material/component suppliers — provide critical components

OEMs / manufacturers — design and produce devices

Technology providers — develop innovative technologies

System integrators / EPCs — integrate devices with other systems

Distributors / channel partners — deliver products to end users

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish and enforce industry standards

In the BGM and CGM ecosystem, control points are primarily held by regulators and standards bodies, as well as large OEMs and technology providers. Dependency risks arise from input constraints, such as component availability, and standards approvals. Switching costs and partnerships are also crucial, as they can impact the interoperability of devices and data systems. Furthermore, the ecosystem differs by region due to varying regulatory requirements and market preferences, highlighting the need for a nuanced understanding of the BGM and CGM value chain analysis.

Recent Industry Insights

The BGM and CGM industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as collaborations between device manufacturers and healthcare providers, have aimed to enhance the accessibility and affordability of blood glucose monitoring systems. Notable mergers and acquisitions have also taken place, with companies seeking to expand their product portfolios and strengthen their market presence.

Furthermore, there have been notable product and technology launches, including the introduction of advanced continuous glucose monitoring systems with improved accuracy and user-friendly interfaces. Regulatory changes have also played a crucial role in shaping the industry, with updates to reimbursement policies and clearance of new devices. These developments have contributed to a shift in consumer and enterprise trends, with a growing emphasis on personalized diabetes management and integrated healthcare solutions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the BGM and CGM market outlook. The market attractiveness is high, driven by the increasing prevalence of diabetes and the growing demand for continuous glucose monitoring systems. The competitive intensity is moderate, with key players investing heavily in research and development to improve the accuracy and affordability of their products.

The long-term outlook for the BGM and CGM market is positive, with the innovation landscape expected to evolve significantly in the next five years. The demand–supply balance is stable, with manufacturers working to meet the growing demand for these devices. However, key risk factors such as regulatory changes and technological disruptions may impact the market. Overall, the BGM and CGM market outlook is favorable, with opportunities for growth and innovation in the coming years.

11 items

1. Executive Summary

2. BGM and CGM Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global BGM and CGM Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global BGM and CGM Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Household

6.1.2. Hospital

6.1.3. Other

6.2. Global BGM and CGM Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. BGM

6.2.2. CGM

6.3. Global BGM and CGM Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global BGM and CGM Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global BGM and CGM Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global BGM and CGM Market Competition by Key Manufacturers

8.1. Global BGM and CGM Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global BGM and CGM: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Dexcom

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Roche

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Lifescan

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Ascensia

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Medtronic

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ARKRAY

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sinocare

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. I-SENS

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Terumo

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. B. Braun

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Acon

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Yicheng

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Omron

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. SD Biosensor

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. 77 Elektronika

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Yuwell

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Osang Healthcare

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. AgaMatrix

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Senseonics Holdings

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global BGM and CGM Market

Figure 4: Global BGM and CGM Market: Drivers

Figure 5: Global BGM and CGM Market: Challenges

Figure 6: Global BGM and CGM Market: Trends

Figure 7: Global BGM and CGM Market: Opportunity

Figure 8: Global BGM and CGM Market: Restraint

Figure 9: Global BGM and CGM Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global BGM and CGM Market Value (USD Million) By Region

Figure 15: Global BGM and CGM Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global BGM and CGM Market Value (USD Million) By Region

Figure 23: Global BGM and CGM Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global BGM and CGM Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global BGM and CGM Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global BGM and CGM Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global BGM and CGM Market Value (USD Million) By Region

Table 10: Global BGM and CGM Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global BGM and CGM Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global BGM and CGM Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global BGM and CGM Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: Dexcom Basic Information And Sales Area

Table 33: Dexcom. Products Portfolio

Table 34: Roche Basic Information And Sales Area

Table 35: Roche. Products Portfolio

Table 36: Lifescan Basic Information And Sales Area

Table 37: Lifescan. Products Portfolio

Table 38: Ascensia Basic Information And Sales Area

Table 39: Ascensia. Products Portfolio

Table 40: Medtronic Basic Information And Sales Area

Table 41: Medtronic. Products Portfolio

Table 42: ARKRAY Basic Information And Sales Area

Table 43: ARKRAY. Products Portfolio

Table 44: Sinocare Basic Information And Sales Area

Table 45: Sinocare. Products Portfolio

Table 46: I-SENS Basic Information And Sales Area

Table 47: I-SENS. Products Portfolio

Table 48: Terumo Basic Information And Sales Area

Table 49: Terumo. Products Portfolio

Table 50: B. Braun Basic Information And Sales Area

Table 51: B. Braun. Products Portfolio

Table 52: Acon Basic Information And Sales Area

Table 53: Acon. Products Portfolio

Table 54: Yicheng Basic Information And Sales Area

Table 55: Yicheng. Products Portfolio

Table 56: Omron Basic Information And Sales Area

Table 57: Omron. Products Portfolio

Table 58: SD Biosensor Basic Information And Sales Area

Table 59: SD Biosensor. Products Portfolio

Table 60: 77 Elektronika Basic Information And Sales Area

Table 61: 77 Elektronika. Products Portfolio

Table 62: Yuwell Basic Information And Sales Area

Table 63: Yuwell. Products Portfolio

Table 64: Osang Healthcare Basic Information And Sales Area

Table 65: Osang Healthcare. Products Portfolio

Table 66: AgaMatrix Basic Information And Sales Area

Table 67: AgaMatrix. Products Portfolio

Table 68: Senseonics Holdings Basic Information And Sales Area

Table 69: Senseonics Holdings. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global BGM and CGM Market Value (USD Million) By Region

Table 75: Global BGM and CGM Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

BGM and CGM Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.00 billion
Revenue forecast in 2033	26.10 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Dexcom; Roche; Lifescan; Ascensia; Medtronic; ARKRAY; Sinocare; I-SENS; Terumo; B. Braun; Acon; Yicheng; Omron; SD Biosensor; 77 Elektronika; Yuwell; Osang Healthcare; AgaMatrix; Senseonics Holdings
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options